The antibody is to treat adult recurrent or metastatic non-keratinising nasopharyngeal carcinoma (NPC) in conjunction with ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular ...